In vitro hydroxyflutmamide induced rapid activation of ras/MAP kinase pathway in human prostate cancer DU145 cells (which lack the androgen receptor) as well as in CWR22 and PC-3AR2 androgen receptor positive cells lines, indicating that the activation did not require androgen receptor. This evidence concerns the gene AR and prostate cancer.